What is the recommended dosage and treatment duration for Augmentin (amoxicillin-clavulanate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin (Amoxicillin-Clavulanate) Dosing Recommendations

For adults with respiratory tract infections, use 875 mg/125 mg twice daily for 5-7 days, or 500 mg/125 mg three times daily for mild-to-moderate infections. 1, 2

Standard Adult Dosing by Infection Severity

Mild to Moderate Infections

  • 500 mg/125 mg three times daily (every 8 hours) for ear/nose/throat, skin/skin structure, and genitourinary tract infections 2
  • Alternative: 875 mg/125 mg twice daily (every 12 hours) for respiratory infections including acute bacterial rhinosinusitis, community-acquired pneumonia, and acute exacerbations of chronic bronchitis 1
  • Duration: 5-7 days for most respiratory infections 1, 3

Severe Infections

  • 875 mg/125 mg twice daily or 500 mg/125 mg three times daily for severe ear/nose/throat, skin, and genitourinary infections 2
  • Lower respiratory tract infections (any severity): 875 mg/125 mg twice daily or 500 mg/125 mg three times daily 2

Intravenous Dosing for Serious Infections

  • 1.2 g IV every 8 hours for complicated intra-abdominal infections, severe respiratory infections, and severe skin/soft tissue infections 1, 3
  • Duration: 4-7 days with adequate source control for intra-abdominal infections 1

Specific Clinical Indications

Community-Acquired Pneumonia

  • Moderate severity (non-ICU): 1.2 g IV every 8 hours 3
  • Outpatient with comorbidities: 1-2 g PO every 12 hours 3
  • Duration: 5-7 days if afebrile for at least 48 hours with no more than one CAP-associated sign of clinical instability 3

Acute Bacterial Rhinosinusitis

  • Mild disease without recent antibiotic use: 500 mg/125 mg three times daily 3
  • Moderate disease or recent antibiotic use (past 4-6 weeks): 4 g/250 mg per day (high-dose formulation) 3
  • Duration: 5-7 days for uncomplicated cases 1

Skin and Soft Tissue Infections

  • Animal or human bites: 500 mg/125 mg twice daily 1
  • Standard infections: 875 mg/125 mg twice daily 1

Methicillin-Susceptible Staphylococcus aureus Pneumonia

  • 1.2 g IV/PO every 8 hours 3
  • Duration: Up to 4 weeks may be considered if S. aureus bacteremia is present 3

Haemophilus influenzae (β-lactamase positive)

  • 1.2 g IV/PO every 12 hours 3
  • Duration: 7-10 days 3

Burkholderia pseudomallei (Eradication phase)

  • 20/5 mg/kg PO every 8 hours, up to maximum of 1500/375 mg PO every 8 hours 3

Pediatric Dosing (≥3 months and <40 kg)

Standard Dosing

  • Mild/moderate infections: 25 mg/kg/day (amoxicillin component) divided every 12 hours or 20 mg/kg/day divided every 8 hours 2
  • Severe infections: 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours 2

High-Dose Regimen for Resistant Organisms

  • 80-90 mg/kg/day (amoxicillin component) with 6.4 mg/kg/day (clavulanate) in 2 divided doses for severe infections or areas with high prevalence of resistant S. pneumoniae (>10%) 4
  • Maximum: 2 g per dose 4

Risk Factors Requiring High-Dose Therapy

  • Age younger than 2 years 4
  • Attendance at childcare 4
  • Recent antimicrobial treatment within previous 30 days 4
  • Moderate to severe illness 4

Infants <3 Months

  • Maximum 30 mg/kg/day divided every 12 hours due to incompletely developed renal function 2

Special Populations

Renal Impairment

  • GFR 10-30 mL/min: 500 mg or 250 mg every 12 hours 2
  • GFR <10 mL/min: 500 mg or 250 mg every 24 hours 2
  • Hemodialysis: 500 mg or 250 mg every 24 hours, with additional dose during and at end of dialysis 2
  • Do NOT use 875 mg dose if GFR <30 mL/min 2

H. pylori Infection (Adults Only)

  • Triple therapy: 1 g twice daily (every 12 hours) with clarithromycin 500 mg and lansoprazole 30 mg for 14 days 2
  • Dual therapy: 1 g three times daily (every 8 hours) with lansoprazole 30 mg for 14 days 2

Critical Dosing Considerations

Formulation Warning

  • Never substitute two 250 mg tablets for one 500 mg tablet as this results in excessive clavulanate dosing 1

Duration Principles

  • Minimum 10 days for Streptococcus pyogenes infections to prevent acute rheumatic fever 2, 1
  • Continue for 48-72 hours beyond clinical improvement or evidence of bacterial eradication 2
  • Longer courses (up to 4 weeks) may be needed for S. aureus bacteremia 3

Administration

  • Take at the start of a meal to minimize gastrointestinal intolerance 2
  • Shake oral suspension well before using 2
  • Discard reconstituted suspension after 14 days 2

Common Pitfalls to Avoid

  • Using standard doses for drug-resistant S. pneumoniae—requires high-dose formulations (4 g/250 mg daily for adults or 80-90 mg/kg/day for children) 3, 4
  • Stopping therapy early for streptococcal infections—always complete 10 days to prevent rheumatic fever 1, 2
  • Using 875 mg dose in severe renal impairment (GFR <30 mL/min)—contraindicated 2
  • Inadequate dosing for pneumonia in ICU patients—requires combination therapy with macrolide or fluoroquinolone 3

References

Guideline

Amoxiclav Dosing Guidelines for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin-Clavulanate Dosage Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.